buildings etcSearch the register →

Recipharm, North Lynn Industrial Estate

RECIPHARM, NORTH LYNN INDUSTRIAL ESTATE, BERGEN WAY, KING S LYNN, NORFOLK, PE30 2JJ

Recipharm, North Lynn Industrial Estate is an industrial building in King S Lynn PE30 2JJ. It has 1 business-rates assessment with a total rateable value of £1,300,000, across about 35,038 m² of rated floor space. The freehold title is registered to Bespak Europe Limited (company 03515896), part of the Eqt Ab group.

Building summary

AddressRECIPHARM, NORTH LYNN INDUSTRIAL ESTATE, BERGEN WAY, KING S LYNN, NORFOLK, PE30 2JJ
Main useFactory and premises
Total rateable value£1,300,000
Rateable assessments1
Rated floor area35,038 m² (377,140 sq ft)
Registered ownerBespak Europe Limited (part of Eqt Ab)
Linked planning applications0

Registered owners

OwnerCompany no.GroupTenureTitle no.
Bespak Europe Limited Operating business03515896Eqt AbFreeholdNK219519

Matched from HM Land Registry ownership data (CCOD/OCOD) to this building by address. Groups are from the Companies House register of people with significant control. Matching is automatic and can be wrong — check the title with HM Land Registry before relying on it.

Common questions

Who owns Recipharm, North Lynn Industrial Estate?

Recipharm, North Lynn Industrial Estate is registered to Bespak Europe Limited (company number 03515896) at HM Land Registry, part of the Eqt Ab group.

What are the business rates for Recipharm, North Lynn Industrial Estate?

Recipharm, North Lynn Industrial Estate has a total rateable value of £1,300,000 across 1 assessment on the Valuation Office Agency's rating list. Business rates bills are worked out from the rateable value, less any reliefs the ratepayer is entitled to.

Other buildings owned by the Eqt Ab group

All buildings owned by the Eqt Ab group →

Nearby buildings

All buildings in PE30 →

Want the full record?

Sign in (free) to see every rateable assessment, valuation breakdowns, current ratepayers and each linked planning application for this building.

Open the full record →